| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advancing tuberculosis drug regimen development through innovative quantitative translational pharmacology methods and approaches
|
Hanna, Debra
|
|
2017
|
56 |
C |
p. 208-211
4 p.
|
artikel
|
| 2 |
A literary approach to tuberculosis: lessons learned from Anton Chekhov, Franz Kafka, and Katherine Mansfield
|
Vilaplana, Cristina
|
|
2017
|
56 |
C |
p. 283-285
3 p.
|
artikel
|
| 3 |
Anti-PD-1/PD-L1 therapy for infectious diseases: learning from the cancer paradigm
|
Rao, Martin
|
|
2017
|
56 |
C |
p. 221-228
8 p.
|
artikel
|
| 4 |
Applicability of the shorter ‘Bangladesh regimen’ in high multidrug-resistant tuberculosis settings
|
Sotgiu, Giovanni
|
|
2017
|
56 |
C |
p. 190-193
4 p.
|
artikel
|
| 5 |
A tuberculosis biomarker database: the key to novel TB diagnostics
|
Yerlikaya, Seda
|
|
2017
|
56 |
C |
p. 253-257
5 p.
|
artikel
|
| 6 |
Classifying new anti-tuberculosis drugs: rationale and future perspectives
|
Tiberi, Simon
|
|
2017
|
56 |
C |
p. 181-184
4 p.
|
artikel
|
| 7 |
De-isolation of patients with pulmonary tuberculosis after start of treatment — clear, unequivocal guidelines are missing
|
Petersen, Eskild
|
|
2017
|
56 |
C |
p. 34-38
5 p.
|
artikel
|
| 8 |
Editorial Board
|
|
|
2017
|
56 |
C |
p. i-
1 p.
|
artikel
|
| 9 |
Enhanced laboratory capacity development: a boost for effective tuberculosis control in resource-limited settings
|
Alabi, Abraham Sunday
|
|
2017
|
56 |
C |
p. 81-84
4 p.
|
artikel
|
| 10 |
European policies in the management of tuberculosis among migrants
|
D’Ambrosio, Lia
|
|
2017
|
56 |
C |
p. 85-89
5 p.
|
artikel
|
| 11 |
Evaluating the impact of healthcare provider training to improve tuberculosis management: a systematic review of methods and outcome indicators used
|
Wu, Shishi
|
|
2017
|
56 |
C |
p. 105-110
6 p.
|
artikel
|
| 12 |
Experimental animal modelling for TB vaccine development
|
Cardona, Pere-Joan
|
|
2017
|
56 |
C |
p. 268-273
6 p.
|
artikel
|
| 13 |
Exploring tuberculosis by molecular tests on DNA isolated from smear microscopy slides
|
Rakotosamimanana, Niaina
|
|
2017
|
56 |
C |
p. 248-252
5 p.
|
artikel
|
| 14 |
Funding for tuberculosis research—an urgent crisis of political will, human rights, and global solidarity
|
Frick, Mike
|
|
2017
|
56 |
C |
p. 21-24
4 p.
|
artikel
|
| 15 |
Health systems in the Republic of Congo: challenges and opportunities for implementing tuberculosis and HIV collaborative service, research, and training activities
|
Linguissi, Laure Stella Ghoma
|
|
2017
|
56 |
C |
p. 62-67
6 p.
|
artikel
|
| 16 |
High-throughput and computational approaches for diagnostic and prognostic host tuberculosis biomarkers
|
Weiner, January
|
|
2017
|
56 |
C |
p. 258-262
5 p.
|
artikel
|
| 17 |
Humoral immune profiling of mycobacterial antigen recognition in sarcoidosis and Löfgren’s syndrome using high-content peptide microarrays
|
Ferrara, Giovanni
|
|
2017
|
56 |
C |
p. 167-175
9 p.
|
artikel
|
| 18 |
Imaging in extrapulmonary tuberculosis
|
Gambhir, Sanjay
|
|
2017
|
56 |
C |
p. 237-247
11 p.
|
artikel
|
| 19 |
Immune recognition surface construction of Mycobacterium tuberculosis epitope-specific antibody responses in tuberculosis patients identified by peptide microarrays
|
Valentini, Davide
|
|
2017
|
56 |
C |
p. 155-166
12 p.
|
artikel
|
| 20 |
Impact of infectious disease epidemics on tuberculosis diagnostic, management, and prevention services: experiences and lessons from the 2014–2015 Ebola virus disease outbreak in West Africa
|
Ansumana, Rashid
|
|
2017
|
56 |
C |
p. 101-104
4 p.
|
artikel
|
| 21 |
Improving access to tuberculosis preventive therapy and treatment for children
|
Marais, Ben J.
|
|
2017
|
56 |
C |
p. 122-125
4 p.
|
artikel
|
| 22 |
Insights gained from ancient biomolecules into past and present tuberculosis—a personal perspective
|
Donoghue, Helen D.
|
|
2017
|
56 |
C |
p. 176-180
5 p.
|
artikel
|
| 23 |
Learning from epidemiological, clinical, and immunological studies on Mycobacterium africanum for improving current understanding of host–pathogen interactions, and for the development and evaluation of diagnostics, host-directed therapies, and vaccines for tuberculosis
|
Zumla, Alimuddin
|
|
2017
|
56 |
C |
p. 126-129
4 p.
|
artikel
|
| 24 |
Less research on tuberculosis than HIV and malaria when research agendas are poorly coordinated: a systematic review of research outputs from Cambodia
|
Khan, Mishal
|
|
2017
|
56 |
C |
p. 25-29
5 p.
|
artikel
|
| 25 |
Mycobacterium tuberculosis proteins involved in cell wall lipid biosynthesis improve BCG vaccine efficacy in a murine TB model
|
Rao, Martin
|
|
2017
|
56 |
C |
p. 274-282
9 p.
|
artikel
|
| 26 |
New tuberculosis drug leads from naturally occurring compounds
|
Quan, Diana
|
|
2017
|
56 |
C |
p. 212-220
9 p.
|
artikel
|
| 27 |
Novel approaches to tuberculosis vaccine development
|
Kaufmann, Stefan H.E.
|
|
2017
|
56 |
C |
p. 263-267
5 p.
|
artikel
|
| 28 |
Pediatric multidrug-resistant tuberculosis clinical trials: challenges and opportunities
|
McAnaw, S.E.
|
|
2017
|
56 |
C |
p. 194-199
6 p.
|
artikel
|
| 29 |
Peptide microarray-based characterization of antibody responses to host proteins after bacille Calmette–Guérin vaccination
|
Valentini, Davide
|
|
2017
|
56 |
C |
p. 140-154
15 p.
|
artikel
|
| 30 |
Preventive therapy for latent tuberculosis infection—the promise and the challenges
|
Fox, G.J.
|
|
2017
|
56 |
C |
p. 68-76
9 p.
|
artikel
|
| 31 |
Quality of tuberculosis care in high burden countries: the urgent need to address gaps in the care cascade
|
Cazabon, Danielle
|
|
2017
|
56 |
C |
p. 111-116
6 p.
|
artikel
|
| 32 |
Removing the bottleneck in whole genome sequencing of Mycobacterium tuberculosis for rapid drug resistance analysis: a call to action
|
McNerney, Ruth
|
|
2017
|
56 |
C |
p. 130-135
6 p.
|
artikel
|
| 33 |
Retrospective study of clinical and lesion characteristics of patients undergoing surgical treatment for Pulmonary Tuberculosis in Georgia
|
Vashakidze, Sergo
|
|
2017
|
56 |
C |
p. 200-207
8 p.
|
artikel
|
| 34 |
Second line drug susceptibility testing to inform the treatment of rifampin-resistant tuberculosis: a quantitative perspective
|
Kendall, Emily A.
|
|
2017
|
56 |
C |
p. 185-189
5 p.
|
artikel
|
| 35 |
Shifting from tuberculosis control to elimination: Where are we? What are the variables and limitations? Is it achievable?
|
Centis, Rosella
|
|
2017
|
56 |
C |
p. 30-33
4 p.
|
artikel
|
| 36 |
Status of Tuberculosis services in Indian Prisons
|
Prasad, Banuru Muralidhara
|
|
2017
|
56 |
C |
p. 117-121
5 p.
|
artikel
|
| 37 |
Strong anti-Epstein Barr virus (EBV) or cytomegalovirus (CMV) cellular immune responses predict survival and a favourable response to anti-tuberculosis therapy
|
Nagu, Tumaini
|
|
2017
|
56 |
C |
p. 136-139
4 p.
|
artikel
|
| 38 |
Tackling TB in low-incidence countries: improving diagnosis and management in vulnerable populations
|
Heuvelings, C.C.
|
|
2017
|
56 |
C |
p. 77-80
4 p.
|
artikel
|
| 39 |
The global dynamics of diabetes and tuberculosis: the impact of migration and policy implications
|
Girardi, Enrico
|
|
2017
|
56 |
C |
p. 45-53
9 p.
|
artikel
|
| 40 |
The risk of global epidemic replacement with drug-resistant Mycobacterium tuberculosis strains
|
McBryde, Emma S.
|
|
2017
|
56 |
C |
p. 14-20
7 p.
|
artikel
|
| 41 |
Tuberculosis and hypertension—a systematic review of the literature
|
Seegert, Anneline Borchsenius
|
|
2017
|
56 |
C |
p. 54-61
8 p.
|
artikel
|
| 42 |
Tuberculosis associated mortality in a prospective cohort in Sub Saharan Africa: Association with HIV and antiretroviral therapy
|
Nagu, Tumaini J.
|
|
2017
|
56 |
C |
p. 39-44
6 p.
|
artikel
|
| 43 |
Tuberculosis eradication versus control
|
Schito, Marco
|
|
2017
|
56 |
C |
p. 10-13
4 p.
|
artikel
|
| 44 |
Tuberculosis stigma as a social determinant of health: a systematic mapping review of research in low incidence countries
|
Craig, G.M.
|
|
2017
|
56 |
C |
p. 90-100
11 p.
|
artikel
|
| 45 |
Turning the tide against tuberculosis
|
Padayatchi, Nesri
|
|
2017
|
56 |
C |
p. 6-9
4 p.
|
artikel
|
| 46 |
Ultrasound for patients in a high HIV/tuberculosis prevalence setting: a needs assessment and review of focused applications for Sub-Saharan Africa
|
Heller, Tom
|
|
2017
|
56 |
C |
p. 229-236
8 p.
|
artikel
|
| 47 |
World TB Day 2017: Advances, Challenges and Opportunities in the “End-TB” Era
|
Petersen, Eskild
|
|
2017
|
56 |
C |
p. 1-5
5 p.
|
artikel
|
Tijdschrift beschrijving